News

Photo

Trusted Evidence in the Age of AI

AI in pharma has moved past the hype cycle and into implementation. The organizations that pull ahead won't have the most sophisticated models — they'll have the strongest evidence foundation underneath them.

Photo

IMCD opens new technical hub

IMCD has extensively modernized the application laboratories for Coatings & Construction and Home Care I&I and has now reopened them at BioCampus Cologne, a technology and innovation campus in Cologne.

Photo

Wacker completes sale of shares in Siltronic

Wacker has sold 2.1 million Siltronic shares for € 89.35 per Siltronic share. The sale corresponds to 7% of Siltronic's share capital and reduces Wacker's stake in Siltronic to around 24%.

14023 more News

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.